Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
30 /100
MEDIUM RISK
Score updated Oct 13, 2026

BLTE — Belite Bio, Inc Dilution Risk Tracker

Track BLTE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BLTE — Get alerts when the score changes →

As of October 13, 2026, Belite Bio, Inc (BLTE) has a DilutionWatch DilutionScore of 30/100, rated MEDIUM dilution risk. Belite Bio, Inc has a market capitalization of $6.24B, 39.34M shares outstanding, 77 institutional holders tracked. Stored dilution-related fields include 1.86M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
0
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for BLTE.
🔔 Track BLTE — Get forecast alerts →

Market Data

Market Cap$6.24B
Shares Outstanding39.34M
Float18.48M
Cash$352.93M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore30/100DilutionWatch score record
Shares Outstanding39.34MVerified float table or market cache
Public Float18.48MVerified float table or market cache
Market Cap$6.24BMarket data cache
Cash Runway114.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants1.86MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 30.0% shares (2026Q1 vs prior)
77 institutional holders · 9.40M shares
#1 Darwin Global Management, Ltd. 3.06M shares
#2 Paradigm Biocapital Advisors LP 1.11M shares
#3 UBS Group AG 768.4K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.06M
Days to Cover7.3
% of Float5.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2023-03-31
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-13
4 INSIDER TRANSACTION 2026-04-13
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual BLTE Dilution Snapshot

Belite Bio, Inc (BLTE) has a DilutionScore of 30/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

BLTE's DilutionScore is currently 30/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 29/100 (Medium risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202630/100MEDIUM16 days
Jul 16 – Sep 27, 202629/100MEDIUM73 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

BLTE shares outstanding have increased 6.9% from 37.51M (Mar 2026) to 40.09M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 202640.09M18.48M▼ 1.86%
May 23, 202640.09M18.83M▲ 1.89%
May 18, 202639.97M18.48M▼ 0.16%
May 10, 202639.97M18.51M▲ 0.01%
May 08, 202639.97M18.51M▲ 0.01%
May 03, 202639.97M18.51M▲ 0.02%
May 02, 202639.97M18.51M▲ 0.02%
Apr 26, 202639.97M18.50M▼ 0.09%
Apr 24, 202639.97M18.52M▲ 0.01%
Apr 15, 202639.97M18.52M▲ 0.08%
Apr 07, 202639.97M18.50M▼ 1.39%
Mar 09, 202637.51M18.76M▲ 5.64%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track BLTE Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment BLTE files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking BLTE — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations